[8-K] James River Group Holdings, Inc. Reports Material Event
James River Group Holdings, Inc. reported a sharp turnaround for the quarter and year ended December 31, 2025. Fourth-quarter net income available to common shareholders was $30.1 million, or $0.53 diluted EPS, compared with a loss of $94.0 million, or $(2.28) per share, a year earlier.
The consolidated combined ratio improved to in the quarter from 155.1%, driven by a loss ratio of 64.9% and a lower expense ratio of 29.2%. Full-year combined ratio was 96.6%, and adjusted net operating income for 2025 reached $54.1 million versus a loss of $41.5 million in 2024.
Tangible common equity was $410.9 million, or $8.94 per share, up from $304.6 million and $6.67 per share at December 31, 2024. Results benefited from a $14.1 million one-time tax benefit tied to the redomicile from Bermuda to Delaware. The Board declared a $0.01 per-share cash dividend payable March 31, 2026 to shareholders of record on March 13, 2026.
Positive
- None.
Negative
- None.
Insights
James River delivered a notable earnings turnaround with stronger underwriting and capital metrics.
James River moved from heavy losses to profitability, posting Q4 2025 net income available to common shareholders of $30.1 million versus a $94.0 million loss a year earlier. The consolidated combined ratio improved to 94.1%, reflecting better underwriting results and lower expenses.
For 2025, the combined ratio was 96.6% and adjusted net operating income was $54.1 million, compared with a $41.5 million loss in 2024. Tangible common equity rose to $410.9 million, or $8.94 per share, supported by earnings and a $14.1 million one-time tax benefit from redomiciling to Delaware.
The Excess and Surplus segment posted an 86.0% combined ratio for Q4, while Specialty Admitted shrank as management emphasized smaller, more profitable accounts. A quarterly dividend of $0.01 per share, payable on March 31, 2026, signals continued, albeit modest, capital returns alongside the balance sheet strengthening.
8-K Event Classification
| Date of Report (Date of earliest event reported): | |||||
(Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Former name or former address, if changed since last report.) | ||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Item 2.02 | Results of Operations and Financial Condition. | ||||
| Item 8.01 | Other Events. | ||||
| Item 9.01 | Financial Statements and Exhibits. | ||||
Exhibit No. | Description | |||||||
99.1 | Press Release of the Company dated March 2, 2026 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| JAMES RIVER GROUP HOLDINGS, INC. | |||||
Dated: March 2, 2026 | By: /s/ Sarah C. Doran | ||||
| Sarah C. Doran | |||||
| Chief Financial Officer | |||||

| Three Months Ended December 31, | Three Months Ended December 31, | ||||||||||||||||||||||
| ($ in thousands, except for share data) | 2025 | per diluted share | 2024 | per diluted share | |||||||||||||||||||
| Net income (loss) from continuing operations available to common shareholders | $ | 30,150 | $ | 0.53 | $ | (92,669) | $ | (2.25) | |||||||||||||||
| Net loss from discontinued operations1 | (46) | $ | — | (1,372) | $ | (0.03) | |||||||||||||||||
| Net income (loss) available to common shareholders | 30,104 | $ | 0.53 | (94,041) | $ | (2.28) | |||||||||||||||||
Adjusted net operating income (loss)2 | 15,962 | $ | 0.30 | (40,803) | $ | (0.99) | |||||||||||||||||
| Three Months Ended December 31, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | ||||||||||||||
| Excess and Surplus Lines | $ | 239,517 | $ | 280,287 | (15) | % | |||||||||||
| Specialty Admitted Insurance | 23,162 | 78,005 | (70) | % | |||||||||||||
| $ | 262,679 | $ | 358,292 | (27) | % | ||||||||||||
| Three Months Ended December 31, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | ||||||||||||||
| Excess and Surplus Lines | $ | 140,693 | $ | 99,684 | 41 | % | |||||||||||
| Specialty Admitted Insurance | 1,443 | 14,307 | (90) | % | |||||||||||||
| $ | 142,136 | $ | 113,991 | 25 | % | ||||||||||||
| Three Months Ended December 31, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | ||||||||||||||
| Excess and Surplus Lines | $ | 140,917 | $ | 87,275 | 61 | % | |||||||||||
| Specialty Admitted Insurance | 6,409 | 18,311 | (65) | % | |||||||||||||
| $ | 147,326 | $ | 105,586 | 40 | % | ||||||||||||
| Three Months Ended December 31, | |||||||||||
| ($ in thousands) | 2025 | 2024 | |||||||||
| Excess and Surplus Lines | $ | 4,959 | $ | (8,943) | |||||||
| Specialty Admitted Insurance | (3,119) | — | |||||||||
| $ | 1,840 | $ | (8,943) | ||||||||
| Three Months Ended December 31, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | ||||||||||||||
| Private Investments | 977 | 1,334 | (27) | % | |||||||||||||
| All Other Investments | 20,020 | 20,628 | (3) | % | |||||||||||||
| Total Net Investment Income | $ | 20,997 | $ | 21,962 | (4) | % | |||||||||||
($ in thousands, except for share data) | December 31, 2025 | December 31, 2024 | |||||||||
| ASSETS | |||||||||||
| Invested assets: | |||||||||||
| Fixed maturity securities, available-for-sale, at fair value | $ | 1,404,774 | $ | 1,189,733 | |||||||
| Equity securities, at fair value | 73,092 | 86,479 | |||||||||
Bank loan participations, at fair value | 155,138 | 142,410 | |||||||||
| Short-term investments | 0 | 97,074 | |||||||||
| Other invested assets | 64,152 | 36,700 | |||||||||
| Total invested assets | 1,697,156 | 1,552,396 | |||||||||
| Cash and cash equivalents | 260,941 | 362,345 | |||||||||
| Restricted cash equivalents (a) | 8,481 | 28,705 | |||||||||
| Accrued investment income | 12,744 | 10,534 | |||||||||
| Premiums receivable and agents’ balances, net | 153,638 | 243,882 | |||||||||
| Reinsurance recoverable on unpaid losses, net | 2,026,110 | 1,996,913 | |||||||||
| Reinsurance recoverable on paid losses | 118,243 | 101,210 | |||||||||
| Deferred policy acquisition costs | 31,286 | 30,175 | |||||||||
| Goodwill and intangible assets | 213,918 | 214,281 | |||||||||
| Other assets | 337,413 | 466,635 | |||||||||
| Total assets | $ | 4,859,930 | $ | 5,007,076 | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||
| Reserve for losses and loss adjustment expenses | $ | 3,099,418 | $ | 3,084,406 | |||||||
| Unearned premiums | 447,644 | 572,034 | |||||||||
| Funds held (a) | 7,485 | 25,157 | |||||||||
| Deferred reinsurance gain | 86,720 | 57,970 | |||||||||
| Senior debt | 225,800 | 200,800 | |||||||||
| Junior subordinated debt | 104,055 | 104,055 | |||||||||
| Accrued expenses | 31,006 | 53,178 | |||||||||
| Other liabilities | 186,534 | 315,446 | |||||||||
| Total liabilities | 4,188,662 | 4,413,046 | |||||||||
| Series A redeemable preferred shares | 133,115 | 133,115 | |||||||||
| Total shareholders’ equity | 538,153 | 460,915 | |||||||||
| Total liabilities, Series A redeemable preferred shares, and shareholders’ equity | $ | 4,859,930 | $ | 5,007,076 | |||||||
| Tangible equity (b) | $ | 544,070 | $ | 437,719 | |||||||
| Tangible equity per share (b) | $ | 9.15 | $ | 7.40 | |||||||
Tangible common equity per share (b) | $ | 8.94 | $ | 6.67 | |||||||
Shareholders' equity per share | $ | 11.71 | $ | 10.10 | |||||||
| Common shares outstanding | 45,968,584 | 45,644,318 | |||||||||
(a) Restricted cash equivalents and the funds held liability includes funds posted by the Company to a trust account for the benefit of a third party administrator handling the claims on the Rasier commercial auto policies in run-off. Such funds held in trust secure the Company's obligations to reimburse the administrator for claims payments, and are primarily sourced from the collateral posted to the Company by Rasier and its affiliates to support their obligations under the indemnity agreements and the loss portfolio transfer reinsurance agreement with the Company. | |||||||||||
(b) See “Reconciliation of Non-GAAP Measures” | |||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||
| ($ in thousands, except for share data) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| REVENUES | |||||||||||||||||||||||
| Gross written premiums | $ | 262,679 | $ | 358,292 | $ | 1,172,319 | $ | 1,431,772 | |||||||||||||||
| Net written premiums | 142,136 | 113,991 | 568,815 | 580,854 | |||||||||||||||||||
| Net earned premiums | 147,326 | 105,586 | 600,288 | 600,196 | |||||||||||||||||||
| Net investment income | 20,997 | 21,962 | 83,440 | 93,089 | |||||||||||||||||||
| Net realized and unrealized gains (losses) on investments | (1,711) | (2,803) | (2,195) | 3,625 | |||||||||||||||||||
| Other income | 1,135 | 1,968 | 6,081 | 10,716 | |||||||||||||||||||
| Total revenues | 167,747 | 126,713 | 687,614 | 707,626 | |||||||||||||||||||
| EXPENSES | |||||||||||||||||||||||
| Losses and loss adjustment expenses (a) | 93,534 | 144,560 | 427,204 | 554,374 | |||||||||||||||||||
| Other operating expenses | 43,372 | 47,068 | 183,964 | 193,198 | |||||||||||||||||||
| Other expenses | 227 | 1,563 | 2,002 | 6,145 | |||||||||||||||||||
| Interest expense | 5,968 | 5,709 | 23,538 | 24,666 | |||||||||||||||||||
| Intangible asset amortization and impairment | 91 | 91 | 363 | 363 | |||||||||||||||||||
| Total expenses | 143,192 | 198,991 | 637,071 | 778,746 | |||||||||||||||||||
| Income (loss) from continuing operations before income taxes | 24,555 | (72,278) | 50,543 | (71,120) | |||||||||||||||||||
| Income tax (benefit) expense on continuing operations | (7,564) | (8,883) | 723 | (7,634) | |||||||||||||||||||
| Net income (loss) from continuing operations | 32,119 | (63,395) | 49,820 | (63,486) | |||||||||||||||||||
| Net loss from discontinued operations | (46) | (1,372) | (2,393) | (17,634) | |||||||||||||||||||
| NET INCOME (LOSS) | $ | 32,073 | $ | (64,767) | $ | 47,427 | $ | (81,120) | |||||||||||||||
| Dividends on Series A preferred shares | (1,969) | (29,274) | (7,876) | (37,149) | |||||||||||||||||||
| NET INCOME (LOSS) AVAILABLE TO COMMON SHAREHOLDERS | $ | 30,104 | $ | (94,041) | $ | 39,551 | $ | (118,269) | |||||||||||||||
| ADJUSTED NET OPERATING INCOME (LOSS) (b) | $ | 15,962 | $ | (40,803) | $ | 54,140 | $ | (41,503) | |||||||||||||||
| INCOME (LOSS) PER COMMON SHARE | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Continuing operations | $ | 0.66 | $ | (2.25) | $ | 0.91 | $ | (2.60) | |||||||||||||||
| Discontinued operations | $ | 0.00 | $ | (0.03) | $ | (0.05) | $ | (0.46) | |||||||||||||||
| $ | 0.66 | $ | (2.28) | $ | 0.86 | $ | (3.06) | ||||||||||||||||
| Diluted (c) | |||||||||||||||||||||||
| Continuing operations | $ | 0.53 | $ | (2.25) | $ | 0.83 | $ | (2.60) | |||||||||||||||
| Discontinued operations | $ | 0.00 | $ | (0.03) | $ | (0.04) | $ | (0.46) | |||||||||||||||
| $ | 0.53 | $ | (2.28) | $ | 0.79 | $ | (3.06) | ||||||||||||||||
| ADJUSTED NET OPERATING INCOME (LOSS) PER COMMON SHARE | |||||||||||||||||||||||
| Basic | $ | 0.35 | $ | (0.99) | $ | 1.18 | $ | (1.07) | |||||||||||||||
| Diluted (c) | $ | 0.30 | $ | (0.99) | $ | 1.03 | $ | (1.07) | |||||||||||||||
| Weighted-average common shares outstanding: | |||||||||||||||||||||||
| Basic | 46,008,023 | 41,237,480 | 45,968,359 | 38,685,003 | |||||||||||||||||||
| Diluted | 60,105,097 | 41,237,480 | 60,013,622 | 38,685,003 | |||||||||||||||||||
| Cash dividends declared per common share | $ | 0.01 | $ | 0.01 | $ | 0.04 | $ | 0.16 | |||||||||||||||
| Ratios: | |||||||||||||||||||||||
| Loss ratio | 64.9 | % | 111.4 | % | 66.4 | % | 86.2 | % | |||||||||||||||
| Expense ratio (d) | 29.2 | % | 43.7 | % | 30.2 | % | 31.4 | % | |||||||||||||||
| Combined ratio | 94.1 | % | 155.1 | % | 96.6 | % | 117.6 | % | |||||||||||||||
| Accident year loss ratio (e) | 65.0 | % | 65.6 | % | 65.3 | % | 66.2 | % | |||||||||||||||
(a) Losses and loss adjustment expenses include $2.1 million of benefit and $28.8 million of expense for deferred retroactive reinsurance gains for the three and twelve months ended December 31, 2025, respectively ($27.0 million and $37.2 million of expense in the respective three and twelve month prior year periods). | |||||||||||||||||||||||
| (b) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||||||||||
(c) The outstanding Series A preferred shares were dilutive for the three and twelve months ended December 31, 2025. Dividends on the Series A preferred shares were added back to the numerator in the calculation and 13,521,634 shares of common stock from an assumed conversion of the Series A preferred shares were included in the denominator. | |||||||||||||||||||||||
(d) Calculated with a numerator comprising other operating expenses less gross fee income (in specific instances when the Company is not retaining insurance risk) included in “Other income” in our Condensed Consolidated Income Statements of $303,000 and $2.4 million for the three and twelve months ended months ended December 31, 2025, respectively ($926,000 and $4.6 million in the respective prior year periods), and a denominator of net earned premiums. | |||||||||||||||||||||||
| (e) Ratio of losses and loss adjustment expenses for the current accident year, excluding development on prior accident year reserves, to net earned premiums for the current year (excluding ceded earned premium associated with adverse development covers covering prior accident years and net earned premium adjustments on certain reinsurance treaties with reinstatement premiums associated with prior years). | |||||||||||||||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||
| Gross written premiums | $ | 239,517 | $ | 280,287 | (14.5) | % | $ | 963,035 | $ | 1,017,029 | (5.3) | % | |||||||||||||||||||||||
| Net written premiums | $ | 140,693 | $ | 99,684 | 41.1 | % | $ | 544,124 | $ | 508,445 | 7.0 | % | |||||||||||||||||||||||
| Net earned premiums | $ | 140,917 | $ | 87,275 | 61.5 | % | $ | 559,490 | $ | 512,237 | 9.2 | % | |||||||||||||||||||||||
| Losses and loss adjustment expenses excluding retroactive reinsurance | (86,377) | (103,327) | (16.4) | % | (358,074) | (448,714) | (20.2) | % | |||||||||||||||||||||||||||
| Underwriting expenses | (34,866) | (36,166) | (3.6) | % | (141,944) | (140,978) | 0.7 | % | |||||||||||||||||||||||||||
| Underwriting profit (loss) (a) | $ | 19,674 | $ | (52,218) | — | $ | 59,472 | $ | (77,455) | — | |||||||||||||||||||||||||
| Ratios: | |||||||||||||||||||||||||||||||||||
| Loss ratio | 61.3 | % | 118.4 | % | 64.0 | % | 87.6 | % | |||||||||||||||||||||||||||
| Expense ratio | 24.7 | % | 41.4 | % | 25.4 | % | 27.5 | % | |||||||||||||||||||||||||||
| Combined ratio | 86.0 | % | 159.8 | % | 89.4 | % | 115.1 | % | |||||||||||||||||||||||||||
| Accident year loss ratio (b) | 63.6 | % | 64.1 | % | 63.5 | % | 64.3 | % | |||||||||||||||||||||||||||
| (a) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||||||||||||||||||||||
| (b) Ratio of losses and loss adjustment expenses for the current accident year, excluding development on prior accident year reserves, to net earned premiums for the current year (excluding ceded earned premium associated with adverse development covers covering prior accident years and net earned premium adjustments on certain reinsurance treaties with reinstatement premiums associated with prior years). | |||||||||||||||||||||||||||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||
| Gross written premiums | $ | 23,162 | $ | 78,005 | (70.3) | % | $ | 209,284 | $ | 414,743 | (49.5) | % | |||||||||||||||||||||||
| Net written premiums | $ | 1,443 | $ | 14,307 | (89.9) | % | $ | 24,691 | $ | 72,409 | (65.9) | % | |||||||||||||||||||||||
| Net earned premiums | $ | 6,409 | $ | 18,311 | (65.0) | % | $ | 40,798 | $ | 87,959 | (53.6) | % | |||||||||||||||||||||||
| Losses and loss adjustment expenses | (9,233) | (14,264) | (35.3) | % | (40,380) | (68,423) | (41.0) | % | |||||||||||||||||||||||||||
| Underwriting expenses | (790) | (3,186) | (75.2) | % | (6,111) | (12,663) | (51.7) | % | |||||||||||||||||||||||||||
| Underwriting (loss) profit (a), (b) | $ | (3,614) | $ | 861 | — | $ | (5,693) | $ | 6,873 | — | |||||||||||||||||||||||||
| (a) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||||||||||||||||||||||
(b) Underwriting results for the three and twelve months ended December 31, 2025 include gross fee income of $2.2 million and $13.4 million, respectively ($4.8 million and $21.0 million in the respective prior year periods). | |||||||||||||||||||||||||||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Excess and Surplus Lines: | |||||||||||||||||||||||
| Loss Ratio | 61.3 | % | 118.4 | % | 64.0 | % | 87.6 | % | |||||||||||||||
| Impact of retroactive reinsurance | (1.5) | % | 30.9 | % | 5.1 | % | 7.3 | % | |||||||||||||||
| Loss Ratio including impact of retroactive reinsurance | 59.8 | % | 149.3 | % | 69.1 | % | 94.9 | % | |||||||||||||||
| Combined Ratio | 86.0 | % | 159.8 | % | 89.4 | % | 115.1 | % | |||||||||||||||
| Impact of retroactive reinsurance | (1.5) | % | 30.9 | % | 5.1 | % | 7.3 | % | |||||||||||||||
| Combined Ratio including impact of retroactive reinsurance | 84.5 | % | 190.7 | % | 94.5 | % | 122.4 | % | |||||||||||||||
| Consolidated: | |||||||||||||||||||||||
| Loss Ratio | 64.9 | % | 111.4 | % | 66.4 | % | 86.2 | % | |||||||||||||||
| Impact of retroactive reinsurance | (1.4) | % | 25.5 | % | 4.8 | % | 6.2 | % | |||||||||||||||
| Loss Ratio including impact of retroactive reinsurance | 63.5 | % | 136.9 | % | 71.2 | % | 92.4 | % | |||||||||||||||
| Combined Ratio | 94.1 | % | 155.1 | % | 96.6 | % | 117.6 | % | |||||||||||||||
| Impact of retroactive reinsurance | (1.4) | % | 25.5 | % | 4.8 | % | 6.2 | % | |||||||||||||||
| Combined Ratio including impact of retroactive reinsurance | 92.7 | % | 180.6 | % | 101.4 | % | 123.8 | % | |||||||||||||||
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Underwriting profit (loss) of the operating segments: | |||||||||||||||||||||||
Excess and Surplus Lines | $ | 19,674 | $ | (52,218) | $ | 59,472 | $ | (77,455) | |||||||||||||||
Specialty Admitted Insurance | (3,614) | 861 | (5,693) | 6,873 | |||||||||||||||||||
| Total underwriting profit (loss) of operating segments | 16,060 | (51,357) | 53,779 | (70,582) | |||||||||||||||||||
| Other operating expenses of the Corporate and Other segment | (7,413) | (6,790) | (33,493) | (34,972) | |||||||||||||||||||
Underwriting profit (loss) (a) | 8,647 | (58,147) | 20,286 | (105,554) | |||||||||||||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | 2,076 | (26,969) | (28,750) | (37,237) | |||||||||||||||||||
| Net investment income | 20,997 | 21,962 | 83,440 | 93,089 | |||||||||||||||||||
| Net realized and unrealized (losses) gains on investments | (1,711) | (2,803) | (2,195) | 3,625 | |||||||||||||||||||
| Other income (expense) | 605 | (521) | 1,663 | (14) | |||||||||||||||||||
| Interest expense | (5,968) | (5,709) | (23,538) | (24,666) | |||||||||||||||||||
| Amortization of intangible assets | (91) | (91) | (363) | (363) | |||||||||||||||||||
| Income (loss) from continuing operations before taxes | $ | 24,555 | $ | (72,278) | $ | 50,543 | $ | (71,120) | |||||||||||||||
(a) Included in underwriting results for the three and twelve months ended December 31, 2025 is gross fee income of $2.2 million and $13.4 million, respectively ($4.8 million and $21.0 million in the respective prior year periods). | |||||||||||||||||||||||
| Three Months Ended December 31, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| ($ in thousands) | Income Before Taxes | Net Income | Loss Before Taxes | Net Loss | |||||||||||||||||||
| Income (loss) available to common shareholders | $ | 22,540 | $ | 30,104 | $ | (102,924) | $ | (94,041) | |||||||||||||||
| Loss from discontinued operations | 46 | 43 | 1,372 | 1,372 | |||||||||||||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | (2,076) | (1,640) | 26,969 | 21,306 | |||||||||||||||||||
| Net realized and unrealized investment losses | 1,711 | 1,352 | 2,803 | 2,214 | |||||||||||||||||||
| Other expenses | 226 | 181 | 1,563 | 1,340 | |||||||||||||||||||
| One-time tax benefit in connection with redomicile | — | (14,078) | — | — | |||||||||||||||||||
| Series A deemed dividends | — | — | 27,006 | 27,006 | |||||||||||||||||||
| Adjusted net operating income (loss) | $ | 22,447 | $ | 15,962 | $ | (43,211) | $ | (40,803) | |||||||||||||||
| Twelve Months Ended December 31, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| ($ in thousands) | Income Before Taxes | Net Income | Loss Before Taxes | Net Loss | |||||||||||||||||||
| Income (loss) available to common shareholders | $ | 40,274 | $ | 39,551 | $ | (125,903) | $ | (118,269) | |||||||||||||||
| Loss from discontinued operations | 2,393 | 2,390 | 17,634 | 17,634 | |||||||||||||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | 28,750 | 22,713 | 37,237 | 29,418 | |||||||||||||||||||
| Net realized and unrealized investment losses (gains) | 2,195 | 1,734 | (3,625) | (2,865) | |||||||||||||||||||
| Other expenses | 1,986 | 1,830 | 6,145 | 5,573 | |||||||||||||||||||
| One-time tax benefit in connection with redomicile | — | (14,078) | — | — | |||||||||||||||||||
| Series A deemed dividends | — | — | 27,006 | 27,006 | |||||||||||||||||||
| Adjusted net operating income (loss) | $ | 75,598 | $ | 54,140 | $ | (41,506) | $ | (41,503) | |||||||||||||||
| December 31, 2025 | September 30, 2025 | December 31, 2024 | September 30, 2024 | ||||||||||||||||||||
| ($ in thousands, except for share data) | |||||||||||||||||||||||
| Shareholders' equity | $ | 538,153 | $ | 503,638 | $ | 460,915 | $ | 530,347 | |||||||||||||||
| Plus: Series A redeemable preferred shares | 133,115 | 133,115 | 133,115 | 144,898 | |||||||||||||||||||
| Plus: Deferred reinsurance gain | 86,720 | 88,796 | 57,970 | 31,001 | |||||||||||||||||||
| Less: Goodwill and intangible assets | 213,918 | 214,009 | 214,281 | 214,372 | |||||||||||||||||||
| Tangible equity | $ | 544,070 | $ | 511,540 | $ | 437,719 | $ | 491,874 | |||||||||||||||
| Less: Series A redeemable preferred shares | 133,115 | 133,115 | 133,115 | 144,898 | |||||||||||||||||||
| Tangible common equity | $ | 410,955 | $ | 378,425 | $ | 304,604 | $ | 346,976 | |||||||||||||||
| Common shares outstanding | 45,968,584 | 45,936,898 | 45,644,318 | 37,829,475 | |||||||||||||||||||
| Common shares from assumed conversion of Series A preferred shares | 13,521,634 | 13,521,634 | 13,521,634 | 6,848,763 | |||||||||||||||||||
| Common shares outstanding after assumed conversion of Series A preferred shares | 59,490,218 | 59,458,532 | 59,165,952 | 44,678,238 | |||||||||||||||||||
| Equity per share: | |||||||||||||||||||||||
| Shareholders' equity | $ | 11.71 | $ | 10.96 | $ | 10.10 | $ | 14.02 | |||||||||||||||
| Tangible equity | $ | 9.15 | $ | 8.60 | $ | 7.40 | $ | 11.01 | |||||||||||||||
| Tangible common equity | $ | 8.94 | $ | 8.24 | $ | 6.67 | $ | 9.17 | |||||||||||||||